Travere Therapeutics is Friday's IBD Stock Of The Day. As the Filspari story gets "sweeter," shares are clearing a fresh buy point. The post IBD Stock Of The Day, Travere Therapeutics, Tests Another Breakout. Can The Stock Get Any 'Sweeter?' appeared first on Investor's Business Daily.
CryptoAlerta — análise de criptomoedas e mercado em tempo real